Signal is active with 1 mentions in latest observed window
Recommended action window: Monitor and triage in normal cycle
NVD description
IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
Priority
LOW
Exploitation
NONE
PoC
NONE
Patch
NONE
Momentum
NONE
If you run products in this scope, you should treat this CVE as relevant to your environment.
1 version affected across 2 products
CVE-2025-36226 IBM Aspera Faspex 5 5.0.0 through 5.0.14.3 is vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code i… https://www.cve.org/CVERecord?id=CVE-2025-36226
Post summary
The post announces CVE-2025-36226, noting that IBM Aspera Faspex versions 5.0.0–5.0.14.3 contain a cross‑site scripting flaw enabling authenticated users to inject arbitrary JavaScript code.
2 of 2 entries
| Part | Vendor | Product | Version | Target SW | Target HW |
|---|---|---|---|---|---|
| App | ibm | aspera_faspex | - | - | - |
| OS | linux | linux_kernel | - | - | - |